Activation of human platelets by cocaine

Circulation

Volumn 88, Issue 3, 1993, Pages 876-883

  Kugelmass, Aaron D ^a   Oda, Atsushi ^a   Monahan, Kevin ^a   Cabral, Claudia ^a   Ware, J Anthony ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cocaine; Fibrinogen; P selectin; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; COCAINE; FIBRINOGEN; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PHORBOL DIBUTYRATE; SEROTONIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SEROTONIN UPTAKE; THROMBOCYTE ACTIVATION; THROMBOSIS;

BLOOD PLATELETS; CELL ADHESION MOLECULES; COCAINE; FIBRINOGEN; FLOW CYTOMETRY; HUMAN; IN VITRO; P-SELECTIN; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOSIS;

EID: 0027162012     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.88.3.876     Document Type: Article

References (49)

1. Minor RL, Scott DS, Brown DD, Winniford MD. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med. 1991;115:797-806.
2. Kloner RA, Hale S, Alker K, Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation. 1992;85:407-419.
3. Delaney K, Hoffman RS. Pulmonary infarction associated with crack cocaine use in a previously healthy 23-year old woman. Am J Med. 1991;91:92-94.
4. Zamora-Quezada JC, Dinerman H, Stadecker MJ, Kelly JJ. Muscle and skin infarction after free-basing cocaine (crack). Ann Intern Med. 1988;108:564-565.
5. Sharff JA. Renal infarction associated with intravenous cocaine use. Ann Emerg Med. 1984;13:1145-1147.
6. Lisse JR, Davis CP, Thurmond-Anderle M. Cocaine abuse and deep venous thrombosis. Ann Intern Med. 1989;110:571-572.
7. Simpson RW, Edwards RD. Pathogenesis of cocaine-induced ischemic heart disease. Arch Pathol Lab Med. 1986;110:479-484.
8. Grant GJ, Ramanathan S, Patel N, Turndorf H. The effects of local anesthetics on maternal and fetal platelet function. Acta Anaesthesiol Scand. 1989;33:409-412.
9. Peerschke EI. Platelet membrane alterations induced by the local anesthetic dibucaine. Blood. 1986;68:463-471.
10. Feinstein MB, Fiekers J, Frazer C. An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion. J Pharmacol Exp Ther. 1976;197:215-228.
11. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70:307-315.
12. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest. 1991;87:571-580.
13. Maschio AD, Evangelista V, Rajtar G, Chen ZM, Cerletti C, de Gaetano G. Activated polymorphonuclear leukocytes stimulate platelet function. Am J Physiol. 1990;258:H870-H879.
14. Bevilacqua M, Butcher E, Furie B, Furie B, Gallatin M, Gimbrone M, Harlan J, Kishimoto K, Lasky L, McEver R, Paulson J, Rosen S, Seed B, Siegelman M, Springer T, Stoolman L, Tedder T, Varki A, Wagner D, Weissman I, Zimmerman G. Selectins: a family of adhesion receptors. Cell. 1991;67:223.
15. Sternberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880-886.
16. Warkentin TE, Fowling MJ, Hardisty RM. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation. Br J Haematol. 1990;76:387-394.
17. Oda A, Daley JF, Kang JH, Smith M, Salzman EW. Heterogeneity in filamentous actin content among individual human blood platelets. Blood. 1992;79:920-927.
18. Oda A, Druker BJ, Smith M, Salzman EW. Association of pp60src with Triton X-100 insoluble residue in human blood platelets requires platelet aggregation and actin polymerization. J Biol Chem. 1992;267:20075-20081.
19. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins: studies on resting and activated platelets in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 1986;78:340-348.
20. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor Blood. 1983;61:99-110.
21. McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem. 1984; 259:9799-9804.
22. Rinderknecht H. Ultra-rapid fluorescent labelling of proteins. Nature Lond. 1963;193:167-168.
23. Lindon JL, McManama G, Kushner L, Merrill EW, Salzman EW. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood. 1986;68:355-362.
24. Muirhead KA, Schmitt TC, Muirhead AR. Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers. Cytometry. 1983;3:251-256.
25. Kato T, Wokalek H, Schopf E, Hovestadt I, Ernst M, Rietschel E, Fischer H. Zymosan-induced chemiluminescence of granulocytes in incubated human whole blood: the role of platelets. Tohoku J Exp Med. 1983;141:423-431.
26. Abi-Younes SA, Ayers ML, Myers AK. Mechanism of ethanol-induced aggregation in whole blood. Thromb Res. 1991;63:481-489.
27. Petty AC, Scrutton MC. Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists? Thromb Res. 1989; 54:151-159.
28. Bevan J, Heptinstall S. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets. Thromb Res. 1983;30:415-423.
29. Togna G, Tempesta E, Togna AR, Dolci N, Cebo B, Caprino L. Platelet responsiveness and biosynthesis of thromboxane and protacyclin in response to in vitro cocaine treatment. Haemostasis. 1985;15:100-107.
30. Ware JA, Smith M, Salzman EW. Synergism of platelet-aggregating agents; role of elevation of cytoplasmic calcium. J Clin Invest. 1987;80:267-271.
31. Saitoh M, Salzman EW, Smith M, Ware JA. Activation of protein kinase C in platelets by epinephrine and A23187: correlation with fibrinogen binding. Blood. 1989;74:2001-2006.
32. Johnston GI, Pickett EB, McEver RP, George JN. Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood. 1987;69:1401-1403.
33. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood. 1991;78: 1730-1737.
34. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 1991:78:1760-1769.
35. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 1992;79:1201-1205.
36. Kugelmass AD, Ware JA. Cocaine and coronary artery thrombosis. Ann Intern Med. 1992;116:776-777.
37. Chiueh CC, Kopin IJ. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J Pharmacol Exp Ther. 1978;205:148-154,
38. Schwartz AB, Boyle W, Janzen D, Jones RT. Acute effects of cocaine on catecholamines and cardiac electrophysiology in the conscious dog. Can J Cardiol. 1988;4:188-192.
39. Virmani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J. 1988;115:1068-1076.
40. Stewart DJ, Inaba T, Tang BK, Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci. 1977;20:1557-1564.
41. Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther. 1978;23:547-552.
42. Paly D, Jatlow P, Van Dyke C, Jeri FR, Byck R. Plasma cocaine concentrations during cocaine paste smoking. Life Sci. 1982;30: 731-738.
43. Van Dyke C, Barash PG, Jatlow P, Byck R. Cocaine: plasma concentrations after intranasal application in man. Science. 1976; 191:859-861.
44. 2+ responsiveness of ferret ventricular myocardium. Br J Pharmacol. 1990;101:679-685.
45. Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary artery narrowing in cocaine addicts. Am J Cardiol. 1990;65:303-308.
46. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17: 1553-1560.
47. Schachne JS, Roberts BH, Thompson PD. Coronary-artery spasm and myocardial infarction associated with cocaine use. N Engl J Med. 1984;310:1665-1666.
48. Lange RA, Cigarroa RG, Yancy CW, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562.
49. Isner JM, Chokshi SK. Cocaine and vasospasm. N Engl J Med. 1989;321:1604-1606. Editorial.